Schechter Investment Advisors LLC Reduces Position in Lam Research Co. (NASDAQ:LRCX)

Schechter Investment Advisors LLC cut its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 3.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,613 shares of the semiconductor company’s stock after selling 66 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Lam Research were worth $1,263,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Orion Capital Management LLC bought a new position in shares of Lam Research in the third quarter worth approximately $25,000. Bollard Group LLC boosted its stake in shares of Lam Research by 60.0% in the second quarter. Bollard Group LLC now owns 40 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 15 shares during the period. BluePath Capital Management LLC bought a new position in shares of Lam Research in the third quarter worth about $28,000. Resurgent Financial Advisors LLC bought a new position in shares of Lam Research in the second quarter worth about $29,000. Finally, OFI Invest Asset Management bought a new position in shares of Lam Research in the third quarter worth about $30,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Lam Research news, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total transaction of $497,381.25. Following the sale, the chief accounting officer now owns 5,492 shares of the company’s stock, valued at approximately $4,221,975. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total transaction of $678,037.50. Following the sale, the director now owns 11,604 shares of the company’s stock, valued at approximately $8,920,575. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $768.75, for a total value of $497,381.25. Following the sale, the chief accounting officer now directly owns 5,492 shares in the company, valued at approximately $4,221,975. The disclosure for this sale can be found here. Insiders have sold a total of 19,895 shares of company stock valued at $15,666,586 over the last quarter. 0.32% of the stock is owned by corporate insiders.

Lam Research Trading Down 0.2 %

Shares of NASDAQ LRCX opened at $965.67 on Thursday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.02 and a current ratio of 3.06. The business’s 50 day moving average price is $903.24 and its 200-day moving average price is $761.16. Lam Research Co. has a fifty-two week low of $478.77 and a fifty-two week high of $1,007.39. The company has a market cap of $126.60 billion, a price-to-earnings ratio of 37.34, a PEG ratio of 3.44 and a beta of 1.51.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.06 by $0.46. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the prior year, the firm earned $10.71 earnings per share. Lam Research’s revenue was down 28.8% compared to the same quarter last year. On average, sell-side analysts expect that Lam Research Co. will post 28.88 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th will be paid a $2.00 dividend. The ex-dividend date of this dividend is Tuesday, March 12th. This represents a $8.00 annualized dividend and a yield of 0.83%. Lam Research’s dividend payout ratio (DPR) is currently 30.94%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on LRCX shares. Barclays upped their price objective on Lam Research from $750.00 to $825.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Stifel Nicolaus upped their price objective on Lam Research from $850.00 to $950.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. The Goldman Sachs Group upped their price objective on Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. TD Cowen boosted their target price on Lam Research from $710.00 to $975.00 and gave the stock an “outperform” rating in a research report on Thursday, January 25th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $900.00 target price on shares of Lam Research in a research report on Monday, March 4th. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $811.68.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.